Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elements of cerebral microvascular ischaemia.

M A Petty1, J G Wettstein

  • 1CNS Pharmacology, Aventis Pharmaceuticals, Inc., Route 202-206, P.O. Box 6800, Bridgewater, NJ 08807, USA. margaret.petty@aventis.com

Brain Research. Brain Research Reviews
|August 23, 2001
PubMed
Summary

Ischaemic stroke injury begins at the blood-brain interface, involving microvascular events. Understanding these mechanisms may reveal new therapeutic strategies for stroke treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.

Molecular psychiatry·2012
Same author

Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.

British journal of pharmacology·2011
Same author

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

British journal of pharmacology·2010
Same author

Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.

British journal of pharmacology·2009
Same author

Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors.

British journal of pharmacology·2008
Same author

Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.

Psychopharmacology·2008

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Pathophysiology

Background:

  • Neuronal cells are traditionally viewed as the primary targets of ischemic insults.
  • However, the initiation of ischemic tissue injury critically involves events at the blood-vascular-parenchymal interface.

Purpose of the Study:

  • To review the mechanisms initiating ischemic tissue injury.
  • To explore potential new therapeutic strategies for ischemic stroke based on a deeper understanding of the cascade.

Main Methods:

  • Review of microvascular events in ischemic stroke.
  • Analysis of the blood-brain barrier disruption cascade.
  • Examination of current and past clinical interventions for stroke.

Main Results:

Related Experiment Videos

  • Ischemic injury involves fibrin accumulation, leukocyte adhesion, basal lamina breakdown, and blood-brain barrier disruption.
  • This leads to edema and hemorrhagic transformation.
  • Intravenous tissue plasminogen activator (tPA) is the only acute intervention showing benefit within 3 hours, despite increased hemorrhage risk.

Conclusions:

  • The intricate cascade of microvascular events is crucial for ischemic injury initiation.
  • Further research into these mechanisms may identify novel targets for stroke intervention.
  • A better understanding could lead to more effective and safer stroke treatments.